Progress Toward a Global Group A Streptococcal Vaccine

被引:34
|
作者
Steer, Andrew C. [1 ,2 ,3 ]
Dale, James B. [4 ]
Carapetis, Jonathan R. [5 ,6 ]
机构
[1] Univ Melbourne, Ctr Int Child Hlth, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Parkville, Vic 3052, Australia
[3] Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[4] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[5] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia
[6] Princess Margaret Hosp Children, Perth, WA, Australia
基金
美国国家卫生研究院;
关键词
PROTEIN-BASED VACCINE; RHEUMATIC-FEVER; ANTIBODIES; IMMUNOGENICITY; IMMUNIZATION; REGION; SAFETY; MICE; EMM;
D O I
10.1097/INF.0b013e318281da11
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:180 / 182
页数:3
相关论文
共 50 条
  • [41] Toward rational vaccine engineering
    Vishweshwaraiah, Yashavantha L.
    Dokholyan, Nikolay, V
    ADVANCED DRUG DELIVERY REVIEWS, 2022, 183
  • [42] Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine
    Brumbaugh, Ariel R.
    Mobley, Harry L. T.
    EXPERT REVIEW OF VACCINES, 2012, 11 (06) : 663 - 676
  • [43] Seven-Year Surveillance of North American Pediatric Group A Streptococcal Pharyngitis Isolates
    Shulman, Stanford T.
    Tanz, Robert R.
    Dale, James B.
    Beall, Bernard
    Kabat, William
    Kabat, Kathleen
    Cederlund, Emily
    Patel, Devendra
    Rippe, Jason
    Li, Zhongya
    Sakota, Varja
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (01) : 78 - 84
  • [44] Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate
    Kabanova, Anna
    Margarit, Immaculada
    Berti, Francesco
    Romano, Maria R.
    Grandi, Guido
    Bensi, Giuliano
    Chiarot, Emiliano
    Proietti, Daniela
    Swennen, Erwin
    Cappelletti, Emilia
    Fontani, Paola
    Casini, Daniele
    Adamo, Roberto
    Pinto, Vittoria
    Skibinski, David
    Capo, Sabrina
    Buffi, Giada
    Gallotta, Marilena
    Christ, William J.
    Campbell, A. Stewart
    Pena, John
    Seeberger, Peter H.
    Rappuoli, Rino
    Costantino, Paolo
    VACCINE, 2010, 29 (01) : 104 - 114
  • [45] New immunization initiatives and progress toward the global control of hepatitis B
    Kane, MA
    Brooks, A
    CURRENT OPINION IN INFECTIOUS DISEASES, 2002, 15 (05) : 465 - 469
  • [46] Development of inactivated poliovirus vaccine from Sabin strains: A progress report
    Okayasu, Hiromasa
    Sein, Carolyn
    Hamidi, Ahd
    Bakker, Wilfried A. M.
    Sutter, Roland W.
    BIOLOGICALS, 2016, 44 (06) : 581 - 587
  • [47] Vaccine progress
    Ito, James I.
    Lyons, Joseph M.
    Diaz-Arevalo, Diana
    Hong, Teresa B.
    Kalkum, Markus
    MEDICAL MYCOLOGY, 2009, 47 : S394 - S400
  • [48] Current Ebola Virus Vaccine Progress
    Marzi, Andrea
    Mire, Chad E.
    BIODRUGS, 2019, 33 (01) : 9 - 14
  • [49] Zika Virus Vaccine: Progress and Challenges
    Shan, Chao
    Xie, Xuping
    Shi, Pei-Yong
    CELL HOST & MICROBE, 2018, 24 (01) : 12 - 17
  • [50] Maternal Antibody at Delivery Protects Neonates From Early Onset Group B Streptococcal Disease
    Baker, Carol J.
    Carey, Vincent J.
    Rench, Marcia A.
    Edwards, Morven S.
    Hillier, Sharon L.
    Kasper, Dennis L.
    Platt, Richard
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (05): : 781 - 788